OMERS ADMINISTRATION Corp purchased a new stake in Ventas, Inc. (NYSE:VTR – Free Report) during the 2nd quarter, HoldingsChannel reports. The firm purchased 39,609 shares of the real estate investment trust’s stock, valued at approximately $3,517,000.
Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Ventas in the 2nd quarter worth $4,953,439,000. Capital World Investors bought a new stake in shares of Ventas during the 4th quarter valued at about $594,116,000. Norges Bank bought a new stake in shares of Ventas during the 4th quarter valued at about $474,571,000. Deutsche Bank AG bought a new stake in shares of Ventas during the 2nd quarter valued at about $451,822,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Ventas by 32,509.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock valued at $359,722,000 after buying an additional 4,634,520 shares during the period. 94.18% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the transaction, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.53% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
View Our Latest Research Report on Ventas
Ventas Price Performance
Shares of VTR opened at $93.84 on Wednesday. The stock has a market cap of $48.14 billion, a PE ratio of 173.79, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The firm’s 50-day simple moving average is $91.76 and its two-hundred day simple moving average is $87.38.
Ventas (NYSE:VTR – Get Free Report) last released its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the business earned $0.87 earnings per share. The business’s revenue was up 21.7% on a year-over-year basis. Analysts anticipate that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Featured Articles
- Five stocks we like better than Ventas
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
